Not all pacemakers are created equal: MRI conditional pacemaker and lead technology

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 9, 2013, Pages 1059-1065

  Ahmed, Fozia Z ^a,b   Morris, Gwilym M ^b   Allen, Stuart ^a   Khattar, Rajdeep ^c   Mamas, Mamas ^a,b   Zaidi, Amir ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

implantable cardiac device; implantable cardioverter defibrillator; magnetic resonance imaging (MRI); pacemaker

Indexed keywords

ALGORITHM; DIAGNOSTIC VALUE; ELECTROMAGNETIC FIELD; HEART RHYTHM; HEART STIMULATION; HEART VENTRICLE FIBRILLATION; HOME MONITORING; HUMAN; IMPLANTABLE PULSE GENERATOR; IMPLANTED HEART PACEMAKER; IONIZING RADIATION; MAGNETIC FIELD; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PATIENT MONITORING; PATIENT SAFETY; PHANTOM; PRIORITY JOURNAL; PULSE OXIMETRY; RADIOFREQUENCY; REVIEW; WHOLE BODY SCINTISCANNING;

IMPLANTABLE CARDIAC DEVICE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAGNETIC RESONANCE IMAGING (MRI); PACEMAKER;

ANIMALS; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT SAFETY; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL;

EID: 84883820202     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12238     Document Type: Review

References (22)

1. National Institute for Health and Clinical Excellence: Chest pain of recent onset: Assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. London: Nice, 2010. Retrieved from: http://guidance.nice.org.uk/cg95.
2. Schellinger PD, Bryan RN, Caplan LR, Detre JA, Edelman RR, Jaigobin C, Kidwell CS, Mohr JP, Sloan M, Sorensen AG, Warach S,: Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurol U S 2010; 177-185.
3. ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: A report of the American College of Cardiology foundation quality strategic directions committee appropriateness criteria working group. J Am Coll Radiol U S 2006; 751-771.
4. Kalin R, Stanton MS,: Current clinical issues for MRI scanning of pacemaker and defibrillator patients. PACE 2005; 28: 326-328.
5. Roguin A, Schwitter J, Vahlhaus C, Lombardi M, Brugada J, Vardas P, Auricchio A, Priori S, Sommer T,: Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008; 10: 336-346.
6. Levine GN, Gomes AS, Arai AE, Bluemke DA, Flamm SD, Kanal E, Manning WJ, Martin ET, Smith JM, Wilke N, Shellock FS,: Safety of magnetic resonance imaging in patients with cardiovascular devices. Circulation 2007; 116: 2878-2891.
7. Cohen JD, Costa HS, Russo RJ,: Determining the risks of magnetic resonance imaging at 1.5 Tesla for patients with pacemakers and implantable cardioverter defibrillators. Am J Cardiol 2012; 110: 1631-1636.
8. MagnaSafe (2010): The MagnaSafe registry. Retrieved January 14, 2013, from http://www.magnasafe.org.
9. Doud D,: MRI with pacers, ICDS: Safe, a few minor issues, says MagnaSafe registry. Retrieved January 14, 2012, from http://theheart.org/article/1396425/ print.do.
10. Gimbel JR,: Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a 'modern' pacemaker. Europace 2009; 11: 1241-1242.
11. Zikria JF, Machnicki S, Rhim E, Bhatti T, Graham RE,: MRI of patients with cardiac pacemakers: A review of the medical literature. Am J Roentgenol 2011; 196: 390-401.
12. Bartsch C, Irnich W, Risse M, Weiler G,: Unexpected sudden death of pacemaker patients during or shortly after magnetic resonance imaging [MRI]. In: XIX Congress of International Academy of Legal Medicine. Milan, Italy, 3-6 September 2003. 174, Abstract no. 114.
13. Gimbel JR, Wilkoff BL, Kanal E, Rozner MA,: Safe, sensible, sagacious: Responsible scanning of pacemaker patients. Euro Heart J 2005; 26: 1683-1684.
14. Doud D, Costa H, Russo R, Martin E, Machado C, Uretsky S, Wolff S, Porter M, Tominaga G, Birgersdotter-Green U, Schaerf R, Florin T, Bloomgarden D, Lampert R, Ponce G,: Determining the risks of magnetic resonance imaging at 1.5 Tesla for patients with pacemakers and implantable cardioverter defibrillators (the MagnaSafe registry). Heart Rhythm 33rd Annual Scientific Sessions, 2012.
15. Götte MJ, Rüssel IK, de Roest GJ, Germans T, Veldkamp RF, Knaapen P, Allaart CP, van Rossum AC,: Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: Current situation and clinical perspective. Neth Heart J 2010; 18: 31-37.
16. Luechinger R, Duru F, Zeijlemaker VA, Scheidegger MB, Boesiger P, Candinas R,: Pacemaker Reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: Are Reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 2002; 25: 1419-1423.
17. Pavlicek W, Geisinger M, Castle L, Borkowski GP, Meaney TF, Bream BL, Gallagher JH,: The effects of nuclear magnetic resonance on patients with cardiac pacemakers. Radiology 1983; 147: 149-153.
18. Luechinger R, Duru F, Scheidegger MB, Boesiger P, Candinas R,: Force and torque effects of a 1.5-Tesla MRI scanner on cardiac pacemakers and ICDs. Pacing Clin Electrophysiol 2001; 24: 199-205.
19. Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K,: Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004; 43: 1315-1324.
20. Shellock FG,: Retrieved January 14, 2013, from http://mrisafety.com/ safety-info.asp.
21. Boston Scientific Corporation. 2012: Fineline II Sterox EZ pacing lead (Published 2012).
22. Wollmann C, Steiner E, Vock P, Ndikung B, Mayr H,: Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead. J Cardiovasc Magnetic Reson 2012; 14: 67.